English, Article edition: A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada Jean A. Maroun; Carl Asche; Francoise Romeyer; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/93473
Physical Description
  • article
Language
  • English

Edition details

Title
  • A Cost Comparison of Oral Tegafur Plus Uracil/​Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada
Author
  • Jean A. Maroun
  • Carl Asche
  • Francoise Romeyer
  • Jayanti Mukherjee
  • Christine Cripps
  • Amit Oza
  • Jamie R. Skillings
  • Jacques Letarte
Physical Description
  • article
Notes
  • Background: Two randomised, controlled trials (n =​ 1396) comparing (i) intravenous fluorouracil (FU) plus oral folinic acid (leucovorin) and (ii) oral tegafur plus uracil (UFT) plus folinic acid for the treatment of metastatic colorectal carcinoma found both regimens to have equivalent efficacy in terms of survival, tumour response and time to disease progression. The UFT/​folinic acid regimen was associated with a better toxicity profile than FU/​folinic acid. Objective: To determine the comparative frequencies and costs of healthcare resources utilised in the treatment of patients with these two regimens from a hospital and government perspective. Design: A cost-minimisation analysis of a subgroup of patients from the trials (n =​ 154) was conducted. Costs considered included those for hospital admissions, outpatient clinics, laboratories, imaging modalities, other diagnostic procedures, physician resources, other health professionals, other procedures such as surgery and transfusion, and concomitant medications. The cost of study medications was not included in the analysis. The endpoint was a total average cost per patient per treatment and per cycle. Results: Patients on the oral UFT regimen had fewer outpatient clinic visits and used fewer laboratory resources than patients treated with FU. However, those on the oral regimen had more days of hospitalisation than the patients treated with the intravenous regimen. Patients treated with UFT used 21% less concomitant medication; however, in both groups these medications accounted for a similar percentage compared with the total costs of the treatment. Physicians Conclusions: In regard to the two therapeutic approaches, the cost of treatment per patient and per cycle using oral UFT/​folinic acid was less than that using intravenous FU/​folinic acid.
  • Antineoplastics, Colorectal-cancer, Cost-minimisation, Fluorouracil, Folinic-acid, Pharmacoeconomics, Tegafur/​uracil, Resource-use
  • RePEc:wkh:phecon:v:21:y:2003:i:14:p:1039-1051
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment